Facetime with Phil: Off-Label Drug Use: Potential Impact on Workers’ Compensation

In the fourth and final Facetime with Phil video blog on Off-Label Drug Use, myMatrixx Chief Clinical Officer, Phil Walls, discusses the potential dangers that may accompany the use of drugs like Subsys (fentanyl sublingual spray) for reasons other than their intended use.

BACK TO ALL VIDEOS

OTHER VIDEOS IN THIS SERIES

DEFINING OFF-LABEL DRUG USE

FDA’S NEW POSITION ON OFF-LABEL DRUG USE

OFF-LABEL VS. INVESTIGATIONAL DRUG USE

ARE COMPOUNDS OFF LABEL OR EXPERIMENTAL?

INAPPROPRIATE WARNINGS FOR OPIOIDS